SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001477932-23-002546
Filing Date
2023-04-14
Accepted
2023-04-14 13:51:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D nbio_sc13d.htm SC 13D 33018
  Complete submission text file 0001477932-23-002546.txt   34243
Mailing Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408
Business Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408 612-961-5656
Nascent Biotech Inc. (Subject) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: SC 13D | Act: 34 | File No.: 005-92600 | Film No.: 23820615
SIC: 2834 Pharmaceutical Preparations

Mailing Address 631 US HWY 1 SUITE 407 N PALM BEACH FL 33408
Business Address
Burke Robert David (Filed by) CIK: 0001973753 (see all company filings)

Type: SC 13D